🇺🇸 GILD — Gilead Sciences, Inc.

Healthcare Compra
← Volver

Precio actual

151,00 USD

Máx. histórico

157,29

205 días

Caída desde máximo

-4,00%

Rango 52 semanas

108,46 – 157,29

Variación hoy

-0,15%

Cierre anterior

151,22

Rango de hoy

149,23 – 151,19

Volumen hoy

5.977.099

Información
Nombre completo
Gilead Sciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
17.000
PER ⓘ
—
Dividend yield
2,17% (puede no estar actualizado)
Precio objetivo analistas
157,41 USD (puede no estar actualizado)
Primera cotización
22/01/1992
Precio actualizado
hace 2 días
Sobre la empresa

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment of adult patients. Further, it provides AmBisome, for the treatment of serious invasive fungal infections; and Veklury for the treatment of COVID-19. Additionally, the company engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company has collaboration agreements with Shenzhen Pregene Biopharma Co., Ltd.; Abingworth; Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Dividendos repartidos Total últimos 12 meses: 3,2200 USD · Yield: 2,13%
Fecha de pago Importe por participación
13/12/2018 0,5700 USD
13/09/2018 0,5700 USD
14/06/2018 0,5700 USD
15/03/2018 0,5700 USD
14/12/2017 0,5200 USD
14/09/2017 0,5200 USD
14/06/2017 0,5200 USD
14/03/2017 0,5200 USD
13/12/2016 0,4700 USD
14/09/2016 0,4700 USD
14/06/2016 0,4700 USD
14/03/2016 0,4300 USD
14/12/2015 0,4300 USD
14/09/2015 0,4300 USD
12/06/2015 0,4300 USD
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
09/03/2021 65,51 66,66 64,27 64,33 -0,65% 3,65% 8.973.300
08/03/2021 64,51 66,66 63,96 64,75 +0,20% 4,19% 10.646.900
05/03/2021 63,42 64,75 63,30 64,62 +2,20% 2,29% 9.761.400
04/03/2021 62,80 64,54 62,53 63,23 +0,76% 3,20% 15.847.200
03/03/2021 62,79 63,32 62,17 62,75 -0,41% 1,83% 7.081.300
02/03/2021 62,50 63,59 62,35 63,01 +0,88% 1,98% 6.844.200
01/03/2021 61,76 62,63 61,65 62,46 +1,73% 1,59% 7.328.800
26/02/2021 62,78 62,79 61,39 61,40 -2,21% 2,23% 10.396.300
25/02/2021 63,77 63,97 62,51 62,79 -1,44% 2,29% 7.685.300
24/02/2021 63,56 64,23 62,81 63,71 +0,05% 2,23% 6.533.100
23/02/2021 63,85 64,16 62,78 63,68 -0,67% 2,16% 8.714.600
22/02/2021 63,93 64,47 63,53 64,11 -0,40% 1,47% 6.597.700
19/02/2021 65,08 65,22 64,27 64,37 -1,32% 1,46% 6.054.600
18/02/2021 64,86 65,46 64,33 65,23 +0,20% 1,74% 6.144.600
17/02/2021 64,33 65,14 63,84 65,10 +0,46% 2,02% 7.725.400
16/02/2021 66,41 66,60 64,52 64,80 -3,12% 3,13% 9.757.000
12/02/2021 66,78 67,27 66,36 66,89 -0,04% 1,36% 3.977.700
11/02/2021 67,20 67,20 66,05 66,92 -0,55% 1,71% 6.029.100
10/02/2021 67,26 68,32 67,10 67,29 -0,01% 1,81% 7.667.900
09/02/2021 67,77 67,84 66,85 67,30 -0,99% 1,46% 6.620.400
08/02/2021 68,50 68,76 67,31 67,97 -0,72% 2,12% 9.599.200
05/02/2021 67,25 69,36 66,71 68,46 +4,00% 3,94% 15.068.200
04/02/2021 64,89 65,99 64,44 65,83 +2,03% 2,39% 7.400.400
03/02/2021 65,21 65,69 64,51 64,52 -0,94% 1,81% 6.421.700
02/02/2021 65,09 65,97 64,21 65,13 +0,05% 2,70% 7.749.300
01/02/2021 66,03 66,27 65,06 65,10 -0,76% 1,83% 6.270.200
29/01/2021 64,20 66,23 64,04 65,60 +1,42% 3,41% 11.724.100
28/01/2021 65,25 66,24 64,00 64,68 -1,22% 3,43% 8.086.400
27/01/2021 65,75 66,92 65,08 65,48 -1,83% 2,80% 9.908.200
26/01/2021 67,72 68,38 66,56 66,70 -2,14% 2,69% 7.125.200